1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Global Benign Prostatic Hyperplasia Devices Market 2015-2019

Global Benign Prostatic Hyperplasia Devices Market 2015-2019

  • June 2015
  • -
  • Infiniti Research Limited
  • -
  • 71 pages

About Benign Prostatic Hyperplasia Device
Benign prostatic hyperplasia is a condition characterized by non-cancerous proliferation of prostate gland cells. This causes the gland to enlarge and, as a result, press against the urethra, constricting urine flow. It is associated with aging, hormone imbalances, and abnormal cell growth. Benign prostatic hyperplasia device is used to perform invasive and MI surgeries to remedy a blocked urethra.
Technavio's analysts forecast the global benign prostatic hyperplasia devices market to grow at a CAGR of 5.05% percent over the period 2014-2019.

Covered in this Report
This report covers the present scenario and growth prospects of the global benign prostatic hyperplasia devices market for the period 2014-2019. The global benign prostatic hyperplasia devices market is divided into six segments based on procedure type: TURP, TUMT, TUNA, laser surgery, prostatic stenting, and others (water-induced thermotherapy, high-intensity frequency ultrasound, and open prostatectomy).
Technavio's report, Global Benign Prostatic Hyperplasia Devices Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and APAC and EMEA; it also covers the global benign prostatic hyperplasia devices market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key Regions
• Americas
• APAC
• EMEA

Key Vendors
• Endo Health Solutions
• Karl Storz
• Lumenis
• Olympus
• Urologix
Other Prominent Vendors
• Boston Scientific
• Coloplast
• Lisa Laser
• Medi-tate
• Medifocus
• Neotract
• ProArc Medical
• UroTech

Market Driver
• Growing Elderly Population
• For a full, detailed list, view our report

Market Challenge
• Alternative Treatment Methods
• For a full, detailed list, view our report

Market Trend
• High Number of Outpatient Procedures
• For a full, detailed list, view our report

Key Questions Answered in this Report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Table Of Contents

Global Benign Prostatic Hyperplasia Devices Market 2015-2019
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market overview
03.2 Product offerings
04. Market Research Methodology
04.1 Market research process
04.2 Research methodology
05. Introduction
06. Market Landscape
06.1 Market overview
06.2 Market size and forecast
06.3 Five forces analysis
07. Benign Prostatic Hyperplasia: An Overview
07.1 Incidence and prevalence
07.2 Major symptoms
08. Market Segmentation by Procedure
08.1 TURP
08.2 Laser surgery
08.3 TUMT
08.4 TUNA
08.5 Prostatic stenting
08.6 Others
09. Geographical Segmentation
09.1 Benign prostatic hyperplasia devices market in Americas
09.1.1 Market size and forecast
09.2 Benign prostatic hyperplasia devices market in EMEA
09.2.1 Market size and forecast
09.3 Benign prostatic hyperplasia devices market in APAC
09.3.1 Market size and forecast
10. Buying Criteria
11. Market Growth Drivers
12. Drivers and Their Impact
13. Market Challenges
14. Impact of Drivers and Challenges
15. Market Trends
16. Trends and Their Impact
17. Vendor Landscape
17.1 Competitive scenario
17.1.1 Key news
17.2 Vendor analysis 2014
17.3 Other prominent vendors
18. Key Vendor Analysis
18.1 Endo International
18.1.1 Key facts
18.1.2 Business overview
18.1.3 Business segmentation by revenue 2013
18.1.4 Business segmentation by revenue 2012 and 2013
18.1.5 Geographical segmentation by revenue 2013
18.1.6 Business strategy
18.1.7 Recent developments
18.1.8 SWOT analysis
18.2 Karl Storz
18.2.1 Key facts
18.2.2 Business overview
18.2.3 Business segmentation
18.2.4 Business strategy
18.2.5 Key developments
18.2.6 SWOT analysis
18.3 Lumenis
18.3.1 Key facts
18.3.2 Business overview
18.3.3 Business segmentation by revenue 2013
18.3.4 Business segmentation by revenue 2012 and 2013
18.3.5 Geographical segmentation by revenue 2013
18.3.6 Business strategy
18.3.7 Recent developments
18.3.8 SWOT analysis
18.4 Olympus
18.4.1 Key facts
18.4.2 Business overview
18.4.3 Business segmentation by revenue 2013
18.4.4 Sales by geography
18.4.5 Business strategy
18.4.6 Key developments
18.4.7 SWOT analysis
18.5 Urologix
18.5.1 Key facts
18.5.2 Business overview
18.5.3 Business strategy
18.5.4 SWOT analysis
19. Other Reports in This Series


List of Exhibits
Exhibit 1: Market research methodology
Exhibit 2: Global benign prostatic hyperplasia devices market 2014-2019 ($ millions)
Exhibit 3: Storage symptoms of benign prostatic hyperplasia
Exhibit 4: Voiding symptoms of benign prostatic hyperplasia
Exhibit 5: Segmentation of global benign prostatic hyperplasia devices market by procedure
Exhibit 6: Segmentation of global benign prostatic hyperplasia devices market by procedure 2014
Exhibit 7: Market analysis of various procedures 2014
Exhibit 8: Segmentation of global benign prostatic hyperplasia devices market by geography 2014
Exhibit 9: Benign prostatic hyperplasia devices market in Americas 2014-2019 ($ millions)
Exhibit 10: Benign prostatic hyperplasia devices market in EMEA 2014-2019 ($ millions)
Exhibit 11: Benign prostatic hyperplasia devices market in APAC 2014-2019 ($ millions)
Exhibit 12: Segmentation of global benign prostatic hyperplasia devices market by geography 2014-2019
Exhibit 13: Global benign prostatic hyperplasia devices market: YoY growth rate 2014-2019
Exhibit 14: Major drivers of global benign prostatic hyperplasia devices market
Exhibit 15: Major challenges in global benign prostatic hyperplasia devices market
Exhibit 16: Major trends in global benign prostatic hyperplasia devices market
Exhibit 17: Endo Health Solutions: Key takeaways
Exhibit 18: Karl Storz: Key takeaways
Exhibit 19: Lumenis: Key takeaways
Exhibit 20: Olympus: Key takeaways
Exhibit 21: Urologix: Key takeaways
Exhibit 22: Endo International: Business segmentation by revenue 2013
Exhibit 23: Endo International: Business segmentation by revenue 2012 and 2013 ($ millions)
Exhibit 24: Endo International: Geographical segmentation by revenue 2013
Exhibit 25: Karl Storz: Business segmentation
Exhibit 26: Lumenis: Business segmentation by revenue 2013
Exhibit 27: Lumenis: Business segmentation by revenue 2012 and 2013 ($ millions)
Exhibit 28: Lumenis: Geographical segmentation by revenue 2013
Exhibit 29: Olympus: Business segmentation by revenue 2013
Exhibit 30: Olympus: Sales by geography 2013

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.